(Total Views: 543)
Posted On: 03/05/2020 5:36:19 PM
Post# of 153930
Partial sarcasm.
After I made the case for pricing leronlimab at 35k a year*, Nader announced the new pricing for the drug would be 35k a year. After I laid out a conservative case for a $300 share price, Nader said at the end of an investors call that the share price could end up being worth high three figures. After I posited leronlimab's use in extreme cases of influenza they announced it's possible use with coronavirus.
*One of the things I mentioned was at that price point it might be used as a prophylaxis for cancer.
After I made the case for pricing leronlimab at 35k a year*, Nader announced the new pricing for the drug would be 35k a year. After I laid out a conservative case for a $300 share price, Nader said at the end of an investors call that the share price could end up being worth high three figures. After I posited leronlimab's use in extreme cases of influenza they announced it's possible use with coronavirus.
*One of the things I mentioned was at that price point it might be used as a prophylaxis for cancer.
(1)
(0)
